Table 1.
Baseline patient characteristics.
| PO (No) | PO (Yes) | p-Value | ||
|---|---|---|---|---|
| All n (%) | 35 (100) | 23 (66) | 12 (34) | |
| Sex (male) n (%) | 29 (83) | 21 (60) | 8 (23) | 0.089 |
| Sex (female) n (%) | 6 (17) | 2 (6) | 4 (11) | |
| Age (years) | 69 ± 9 | 67 ± 9 | 72 ± 7 | 0.122 |
| EF (%) | 61 ± 8 | 60 ± 7 | 63 ± 10 | 0.415 |
| Diabetes n (%) | 6 (17) | 3 (9) | 3 (9) | 0.329 |
| Hypertension n (%) | 13 (37) | 9 (26) | 4 (11) | 0.517 |
| Smoking habits n (%) | 8 (23) | 6 (17) | 2 (6) | 0.429 |
| Familiarity for CHD n (%) | 10 (29) | 8 (23) | 2 (6) | 0.236 |
| Dyslipidemia n (%) | 19 (54) | 12 (34) | 7 (20) | 0.505 |
| Symptoms n (%) | 16 (46) | 6 (17) | 10 (29) | 0.002 ** |
| Multivessel CAD n (%) | 21 (60) | 11 (31) | 10 (29) | 0.045 * |
| Ischemia n (%) | 12 (34) | 3 (9) | 9 (26) | 0.0001 ** |
| Ischemic burden (%) | 9 ±3 | 1 ± 2 | 7 ± 5 | 0.0001 ** |
| CMR-Tissue Tracking CCS group | ||||
| GLS (%) | −16 ± 2 | −17 ± 1 | −14 ± 2 | 0.0001 ** |
| GCS (%) | −17 ± 3 | −17 ± 2 | −17 ± 4 | 0.489 |
| GRS (%) | 28 ± 7 | 27 ± 6 | 29 ± 10 | 0.147 |
| CMR-Tissue Tracking Healthy group | ||||
| GLS (%) | −18 ± 1 | |||
| GCS (%) | −20 ± 2 | |||
| GRS (%) | 36 ± 6 |
PO: primary outcomes; EF: ejection fraction; CHD: coronary heart disease; CAD: coronary artery disease; CMR: cardiac magnetic resonance; GLS: global longitudinal strain; GCS: global circumferential strain; GRS: global radial strain. significant difference *: level of significance: p-value < 0.05; ** significant difference: level of significance: p-value < 0.01.